Study of virulence factors in coagulase-negative staphylococci isolated from newborns

Memorias do Instituto Oswaldo Cruz

Volumn 101, Issue 6, 2006, Pages 661-668

  Da Cunha, Maria De Lourdes Ribeiro De Souza ^a   Rugolo, Ligia Maria Suppo De Souza ^a   Lopes, Carlos Alberto De Magalhães ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Coagulase negative staphylococci; Enzymes; Slime; Toxins; Virulence factors

Indexed keywords

STAPHYLOCOCCUS; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 33749834440     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/s0074-02762006000600014     Document Type: Article

References (40)

1. Baddour LM, Christensen GD, Bisno AL 1984. Production of experimental endocarditis by coagulase-negative staphylococci: variability in species virulence. J Infect Dis 150: 721-727.
2. Bergdoll MS, Chesney PJ 1991. Toxic Shock Syndrome, CRC Press, Boca Raton, 234 pp.
3. Christensen GD, Parisi JT, Bisno AL, Simpson WA, Beachey EH 1983. Characterization of clinically significant strains of coagulase-negative staphylococci. J Clin Microbiol 18: 258-269.
4. Christensen GD, Simpson WA, Bisno AL, Beachey EH 1982. Adherence of slime-producing strains of Staphylococcus epidermidis to smooth surfaces. Infect Immun 37: 318-326.
5. Crass BA, Bergdoll MS 1986. Involvement of coagulase-negative staphylococci in toxic shock syndrome. J Clin Microbiol 23: 43-45.
6. Cunha MLRS, Sinzato YK, Silveira LVA 2004. Comparison of methods for the identification of coagulase-negative Staphylococcus. Mem Inst Oswaldo Cruz 99: 855-860.
7. Davenport DS, Masanari RM, Pfaller MA, Bale MJ, Hierholzer WJ 1986. Usefulness of a test for slime production as a marker for clinically significant infections with coagulase-negative staphylococci. J Infect Dis 153: 332-339.
8. Donnelly CB, Leslie JE, Black LA, Lewis KH 1967. Serological identification of enterotoxigenic staphylococci from cheese. Appl Microbiol 15: 1382-1387.
9. Edmond MB, Wallace SE, McClish DK, Pfaller MA, Jones RN, Wenzel RP 1999. Nosocomial bloodstream infections in United States hospitals: a three-year analysis. Clin Infect Dis 29: 239-244.
10. Fleer A, Verhoef J 1984. New aspects of staphylococcal infections: emergence of coagulase-negative staphylococci as pathogens. Antonie Leeuwenhoek 50: 729-744.
11. Fleurette J, Bes M, Brun Y, Freney J, Forey F, Coulet M, Reverdy ME, Etienne J 1989. Clinical isolates of Staphylococcus lugdunensis and S. schleiferi: bacteriological characteristics and susceptibility to antimicrobial agents. Res Microbiol 140: 107-118.
12. Freney J, Brun Y, Bes M, Meugnier H, Grimont F, Grimont PAD, Nervi C, Fleurette J 1988. Staphylococcus lugdunensis sp. nov. and Staphylococcus schleiferi sp. nov., two species from human clinical specimens. Int J Syst Bacteriol 38: 168-172.
13. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM 1996. CDC definitions for nosocomial infections. In RN Olmsted, APIC Infection Control and Applied Epidemiology: Principles and Practice, Mosby , St. Louis, p. A1-A20.
14. Gaynes RP, Edwards JR, Jarvis WR, Culver DH, Tolson JS, Martone WJ 1996. Nosocomial infections among neonates in high-risk nurseries in the United States. Pediatrics 98: 357-361.
15. Gemmell CG 1987. Exo-proteins of coagulase-negative staphylococci as possible virulence factors. Zentralb Bakteriol Mikrobiol Hyg Abt 1 16 (Suppl.): 93-102.
16. Gramoli JL, Wilkinson BJ 1978. Characterization and identification of coagulase-negative heat-stable deoxyribonuclease-positive staphylococci. J Gen Microbiol 105: 275-285.
17. Gray ED, Peters G, Verstegen M, Regelmenn WE 1984. Effect of extracellular slime substance from Staphylococcus epidermidis on the human cellular immune response. Lancet 1: 365-367.
18. Hall RT, Hall SL, Barnes WG, Izuegbu J, Rogolsky M, Zorbas I 1987. Characteristics of coagulase-negative staphylococci from infants with bacteremias. Pediatr Infect Dis J 6: 377-383.
19. Jessen O, Faber V, Rosendal K, Eriksen KR 1959. Some properties of Staphylococcus aureus, possibly related to pathogenicity. I. A study of 446 strains from different types of human infection. Acta Pathol Microbiol Scand 47: 316-326.
20. Kacica MA, Horgan MJ, Ochoa L, Sandler R, Lepow ML, Venezia R 1994. Prevention of gram-positive sepsis in neonates weighing less than 1500 grams. J Pediatr 125: 253-258.
21. Kilpatrick L, Harris MC 1998. Cytokines and the inflammatory response. In RA Polin, WW Fox (eds), Fetal and Neonatal Physiology, WB Saunders, Philadelphia, p. 1967-1989.
22. Kloos WE, Bannerman TL 1995. Staphylococcus and Micrococcus. In PR Murray, EJ Baron, MA Pfaller, FC Tenover, RH Yolken (eds), Manual of Clinical Microbiology, American Society Microbiology, Washington, p. 282-298.
23. Kloos WE, Schleifer KH 1975. Simplified scheme for routine identification of human Staphylococcus species. J Clin Microbiol 1: 82-88.
24. Koneman EW, Allen SD, Janda WM, Schreckenberger PC, Winn Jr WC 1997. Color Atlas and Textbook of Diagnostic Microbiology, JB Lippincott, Philadelphia, 1395 pp.
25. Kreiswirth BN, Schlievert PM, Novick RP 1987. Evaluation of coagulase-negative staphylococci for ability to produce toxic shock syndrome toxin 1. J Clin Microbiol 25: 2028-2029.
26. Lachica RUF, Genigeorgis C, Hoeprich PD 1971. Metachromatic agar-diffusion methods for detecting staphylococcal nuclease activity. Appl Microbiol 21: 585-587.
27. Lambe Jr DW, Ferguson KP, Keplinger JL, Gemmell CG, Kalbfleisch JH 1990. Pathogenicity of Staphylococcus lugdunensis, Staphylococcus schleiferi, and three other coagulase-negative staphylococci in a mouse model and possible virulence factors. Can J Microbiol 36: 455-463.
28. Lark RL, Chenoweth C, Saint S, Zemencuk JK, Lipsky BA, Plorde JJ 2000. Four year prospective evaluation of nosocomial bacteremia: epidemiology, microbiology, and patient outcome. Diagn Microbiol Infect Dis 38: 131-140.
29. Marrack P, Kappler J 1990. The staphylococcal enterotoxins and their relatives. Science 248: 705-717.
30. Manroe BL, Weinberg AG, Rosenfeld CR, Browne R 1979. The neonatal blood count in health and disease. I. Reference values for neutrophilic cells. J Pediatr 95: 89-98.
31. Nataro JP, Corcoran L, Zirin S, Swink S, Taichman N, Goin J, Harris MC 1994. Prospective analysis of coagulase-negative staphylococcal infection in hospitalized infants. J Pediatr 125: 798-804.
32. Neumeister B, Kastner S, Conrad S, Klotz G, Bartmann P 1995. Characterization of coagulase-negative staphylococci causing nosocomial infections in preterm infants. Eur J Clin Microbiol Infect Dis 14: 856-863.
33. Owens JJ 1974. The egg yolk reaction produced by several species of bacteria. J Appl Bacteriol 37: 137-148.
34. Parsonnet J, Harrison AE, Spencer SE, Reading A, Parsonnet KC, Kass EH 1987. Nonproduction of toxic shock syndrome toxin 1 by coagulase-negative staphylococci. J Clin Microbiol 25: 1370-1372.
35. Patrick CC, Plaunt MR, Hetherington SV, May SM 1992. Role of the Staphylococcus epidermidis slime layer in experimental tunnel tract infections. Infect Immun 60: 1363-1367.
36. Pereira ML, Heneine LGD, Pereira JL, Bergdoll MS 1997. Control of nonspecific reactions on reversed passive latex agglutination assay (RPLA) for detecting nanogram quantities of staphylococcal enterotoxins. Arq Bras Med Vet Zootec 49: 493-497.
37. Riley TV, Schneider PF 1992. Infrequency of slime production by urinary isolates of Staphylococcus saprophyticus. J Infect 24: 63-66.
38. Shingaki M, Igarashi H, Fujikawa H, Ushioda H, Terayama T, Sakai S 1981. Study on reversed passive latex agglutination for the detection of staphylococcal enterotoxins A-C. Annu Rep Tokyo Metr Res Lab Publ Hlth 32: 128-131.
39. Valle J, Vadillo S, Piriz S, Gomez-Lucia E 1991. Toxic Shock Syndrome Toxin 1 (TSST-1) production by staphylococci isolated from goats and presence of specific antibodies to TSST-1 in serum and milk. Appl Environ Microbiol 57: 889-891.
40. Vogel L, Jacobus HS, Spaargaren J, Suiker I, Dijkshoorn L 2000. Biofilm production by Staphylococcus epidermidis isolates associated with catheter related bacteremia. Diagn Microbiol Infect Dis 30: 138-141.